Overview Request Sample Pages Request Customization Download PDF
You are viewing: Japan Immunoassay Market analysis
Part of: Immunoassay Market (Global)

The Japan Immunoassay Market was valued at $2214.52 Million in 2025 and projected to reach to $3135.56 Million by 2030, representing a compound annual growth rate of CAGR 7.2%. Japan's immunoassay market is positioned for sustained growth through 2030, driven by the nation's aging population requiring increased diagnostic testing and the healthcare system's emphasis on precision medicine.

Japan Immunoassay Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Immunoassay Market Trends and Insights

  • Japan's advanced healthcare infrastructure and aging population are driving demand for diagnostic immunoassay solutions across clinical laboratories and hospitals.
  • The market in Japan benefits from strong adoption of automated immunoassay platforms and increasing prevalence of chronic diseases requiring routine screening. Japan's immunoassay sector is characterized by high-quality diagnostic standards and significant investment in healthcare technology.
  • Between 2025 and 2030, Japan is expected to see accelerated growth driven by rising healthcare expenditure, expansion of point-of-care testing, and growing awareness of early disease detection.
  • Japan's regulatory environment and emphasis on precision medicine further support market expansion during the forecast period. The immunoassay market in Japan remains competitive, with both established multinational players and domestic manufacturers contributing to innovation and market penetration.
  • Japan's focus on healthcare quality and patient outcomes positions the country as a key growth market within the Asia Pacific region through 2030..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.2%
  • Market Size, 2025 ~USD 2214.52 Million
  • Forecast, 2030 ~USD 3135.56 Million
  • Country Japan

Japan Immunoassay Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing demand for diagnostic immunoassay solutions in clinical settings and hospitals across the country.

Advanced Healthcare Infrastructure :

Japan's world-class healthcare system and high healthcare spending per capita support widespread adoption of automated immunoassay platforms and point-of-care testing devices in medical facilities.

Strong Market Growth Trajectory :

The Japanese immunoassay market is expanding at 7.2% CAGR from 2025 to 2030, outpacing the global growth rate of 6.1%, reflecting robust domestic demand and technological advancement.

Automation and Laboratory Efficiency :

Japanese clinical laboratories are increasingly adopting automated immunoassay systems to improve throughput, reduce turnaround times, and enhance diagnostic accuracy in high-volume testing environments.

Japan Immunoassay Market Dynamics

  • The market's 7.2% CAGR reflects strong adoption of advanced diagnostic technologies in clinical laboratories and hospitals nationwide.
  • Japan's commitment to healthcare innovation and early adoption of automation technologies will continue to support market expansion.
  • Additionally, rising prevalence of chronic diseases and infectious conditions among elderly populations will fuel demand for reliable immunoassay testing solutions across diverse clinical applications..

Market Ecosystem

logo-mobile

IMMUNOASSAY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
 Provides automated immunoassay testing through the Alinity i and ARCHITECT systems for clinical laboratory and blood screening applications. Improves testing throughput within a compact footprint | Supports broad testing menus | Provides greater walk-away time through automated workflows | Supports consistent and reliable results.
company logo
 Provides automated immunoassay testing through cobas e analyzers using electrochemiluminescence technology across infectious disease, cardiac, endocrine, fertility, and oncology applications. Provides high sensitivity and reproducibility through ECL technology | Supports high-throughput testing | Enables continuous reagent loading during operation | Supports carryover-free sample processing.
company logo
 Provides immunoassay testing through Atellica IM, ADVIA Centaur, and IMMULITE systems across infectious disease, cardiac, endocrine, and reproductive health testing. Supports high immunoassay testing throughput | Enables rapid turnaround for key assays | Provides automated QC and remote monitoring | Supports broad assay menus and scalable laboratory configurations.
company logo
 Provides automated immunoassay testing through DxI and Access analyzers for clinical laboratories with varying testing volumes. Provides high productivity per laboratory footprint | Reduces routine maintenance requirements | Supports remote real-time system monitoring | Enables expanded assay processing and laboratory productivity.
company logo
 Provides Bio-Plex multiplex immunoassays and ELISA-based solutions for biomarker, cytokine, protein, and antibody analysis across research and clinical applications. Enables simultaneous measurement of multiple analytes | Reduces sample volume requirements | Supports high-throughput biomarker analysis | Provides automated data analysis and reproducible assay performance.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Japan's immunoassay market will grow from $2,214.52M (2025) to $3,135.56M (2030) at a 7.2% CAGR, outpacing global growth.
      • Japan's aging demographic and advanced healthcare infrastructure drive sustained demand for diagnostic immunoassay testing.
      • Automation and point-of-care testing expansion are key growth catalysts in Japan's immunoassay market through 2030.
      • Japan's regulatory standards and precision medicine focus position it as a premium market within Asia Pacific.

      Immunoassay Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment CLIA (Technology)
      Forecast Period 2025–2030
      Growth Rate CAGR of 6.1% from 2025 to 2030
      Largest Segment REAGENTS & KITS (Product)
      Market Size Base Year (Billions) ~USD 35.48 (2025)
      Revenue Forecast (Billions) ~USD 47.7 (2030)
      Segments Covered Product, Type, Purchase Mode, Technology, Specimen, Application

      Japan Immunoassay Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Analyzers
      • Reagents & Kits

      By Type

      • Clia Reagents & Kits
      • Closed-Ended Systems
      • Elisa Reagents & Kits
      • Elispot Reagents & Kits
      • Ifa Reagents & Kits
      • Open-Ended Systems
      • Other Reagents & Kits
      • Rapid Test Reagents & Kits
      • Western Blot Reagents & Kits

      By Purchase Mode

      • Outright Purchase
      • Rental Purchase

      By Technology

      • Clia
      • Elisa
      • Elispot
      • Ifa
      • Other Technologies
      • Rapid Tests
      • Western Blotting

      By Specimen

      • Blood
      • Other Specimens
      • Saliva
      • Urine

      By Application

      • Allergy Diagnostics
      • Autoimmune Disorders
      • Blood Screening
      • Bone & Mineral Disorders
      • Cardiology
      • Drug Monitoring & Testing
      • Endocrinology
      • Infectious Diseases
      • Newborn Screening
      • Oncology
      • Other Applications

      JAPAN: IMMUNOASSAY MARKET, BY END USER, 2023–2030

      Segment2023202420252026202820292030CAGR (%)
      BLOOD BANKS64.4865.96870.9979.3885.0191.816.2
      CLINICAL LABORATORIES686.91711.19743.52786.37902.51979.231071.47.6
      HOME CARE SETTINGS85.7888.0291.295.59107.75115.86125.636.6
      HOSPITALS & CLINICS1618.291664.491728.711816.282057.042217.082409.626.9
      TOTAL2455.462529.62631.432769.233146.683397.183698.467

      Target Audience

      • In Vitro Diagnostics Manufacturers : IVD companies need Japan-specific market data to assess market size, growth potential, competitive positioning, and develop localized product strategies for this high-income healthcare market.
      • Clinical Laboratory Operators : Laboratory managers require market insights to benchmark performance, identify automation investment opportunities, and understand demand trends for immunoassay testing services in Japan.
      • Healthcare Investment Firms : Private equity and venture capital investors need detailed Japan market analysis to evaluate acquisition targets, assess growth potential, and make informed investment decisions in the diagnostics sector.
      • Hospital and Healthcare Networks : Hospital procurement teams need Japan market data to evaluate immunoassay platform options, understand pricing trends, and optimize diagnostic service delivery and budgeting.
      • Medical Device Distributors : Distribution partners require Japan-specific market intelligence to identify growth opportunities, understand customer preferences, and develop effective sales and marketing strategies for immunoassay products.

      Key Companies in the Japan Immunoassay Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug Product Services (oral, sterile, packaging, lifecycle),Pharmaceutical Development Services (preclinical to clinical),Drug Substance Services (small-molecule and biologics APIs),
      ALERE INCUnited StatesPrivate CompanyInfectious disease diagnostics (rapid and serology, including ELISA and automated systems),Cardiometabolic and critical care point-of-care (blood gas, lipids, glucose, D-dimer, troponin, diabetes),Toxicology and workplace drug testing (devices, reagents, lab services, alcohol tests),
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining and metals, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, nuclear security, logistics, mission-critical O&M),
      CEPHEID INC.United StatesPrivate CompanyInfectious disease & healthcare-associated infection assays (Xpert on GeneXpert),Virology assays (including emergency use authorization tests),Oncology and genetics assays,
      IMMUCOR, INC.United StatesPrivate CompanyTransfusion (serology instruments and reagents, including NEO, Echo, Capture),Transplant & Molecular (HLA, HPA assays, Array Imaging System, BASIS, platelet-focused products),Other / Services and Ancillary Products,
      UNILABSSwitzerlandPrivate CompanyRoutine & Specialty Laboratory Testing,Medical Imaging,Pathology & Centres of Excellence (IVF, Fertility, Pregnancy, Targeted Diagnostics),
      EIKEN CHEMICAL CO., LTD.JapanPublic CompanyFecal immunochemical test (FIT) reagents and analyzers,Microbiological reagents and food/environmental microbiology,Urinalysis test strips and analyzers,
      ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      DANAHERUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (analytical instruments, genomics, and lab automation),Diagnostics (clinical instruments and consumables),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      REVVITYUnited StatesPublic CompanyDiagnostics instruments and systems,Diagnostics reagents, assays, and consumables,Life science reagents and genomic workflow tools,
      DIASORIN S.P.A.ItalyPublic CompanyImmunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology, Metabolic Disorders, Tumor Markers, Oncology,Molecular Diagnostics – Simplexa and Congenital CMV,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Tools,Other / Informatics & Software,
      QUIDELORTHO CORPORATIONUnited StatesPublic CompanyLabs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care,
      BIOMÉRIEUXFrancePublic CompanyClinical microbiology & AST (VITEK, CHROMID, ETEST, culture media, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays & biomarkers (VIDAS, Hybiome CLIA),
      QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Molecular diagnostics assays (TB, immune response, oncology, sexual and reproductive health),Research PCR and enzymes (qPCR, digital PCR, RT-PCR, configured solutions),
      SYSMEX CORPORATIONJapanPublic CompanyHematology analyzers & reagents,Coagulation diagnostics,Urinalysis, blood gas, electrolyte,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring and life support (monitoring, ventilators, defibrillation, AED, anesthesia),Ultrasound and medical imaging (ultrasound, radiology, endoscope camera system),In-vitro diagnostics (CLIA, chemistry, hematology, laboratory diagnostics),

      PATHEON INC

      Patheon Inc. is a Netherlands-based pharmaceutical manufacturing company with 9,100 employees. Operating as a private company, it provides contract development and manufacturing services to the pharmaceutical industry.

      ALERE INC

      Alere Inc. is a United States-based diagnostics company founded in 1981 with 9,700 employees. Operating as a private company, it specializes in rapid diagnostic testing solutions for healthcare markets.

      FLUOR CORPORATION

      Fluor Corporation is a United States-based engineering and construction company founded in 1912 with 22,995 employees. As a public company, it provides design, engineering, procurement, and construction services across multiple industries.

      CEPHEID INC.

      Cepheid Inc. is a United States-based molecular diagnostics company founded in 1996 with 1,700 employees. Operating as a private company, it develops and manufactures automated molecular testing systems.

      IMMUCOR, INC.

      Immucor, Inc. is a United States-based immunohematology company founded in 1982 with 1,125 employees. As a private company, it specializes in blood bank and transfusion medicine diagnostic solutions.

      UNILABS

      Unilabs is a Switzerland-based clinical laboratory services company founded in 1987 with 1,897 employees. As a private company, it operates diagnostic laboratories across multiple European countries.

      EIKEN CHEMICAL CO., LTD.

      Eiken Chemical Co., Ltd. is a Japan-based diagnostics and pharmaceutical company founded in 1939 with 696 employees. As a public company, it manufactures in vitro diagnostic reagents and pharmaceutical products.

      ABBOTT

      Abbott is a United States-based healthcare company founded in 1888 with 115,000 employees. As a public company, it develops and manufactures diagnostics, medical devices, pharmaceuticals, and nutritional products.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a Germany-based medical technology company founded in 1896 with 72,369 employees. As a public company, it manufactures and distributes diagnostic imaging, laboratory diagnostics, and point-of-care testing systems.

      DANAHER

      Danaher is a United States-based conglomerate founded in 1969 with 59,000 employees. As a public company, it operates across multiple sectors including life sciences, diagnostics, and environmental solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based life sciences company founded in 1956 with 125,000 employees. As a public company, it provides laboratory equipment, reagents, and analytical instruments globally.

      REVVITY

      Revvity is a United States-based life sciences and diagnostics company founded in 1937 with 11,000 employees. As a public company, it manufactures and distributes analytical instruments and reagents for research and diagnostics.

      DIASORIN S.P.A.

      DiaSorin S.p.A. is an Italy-based diagnostics company founded in 1968 with 3,242 employees. As a public company, it develops and manufactures in vitro diagnostic products for clinical laboratories.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based life sciences company founded in 1952 with 7,450 employees. As a public company, it manufactures and distributes reagents, instruments, and quality control products for clinical and research laboratories.

      QUIDELORTHO CORPORATION

      QuidelOrtho Corporation is a United States-based diagnostics company founded in 1979 with 6,500 employees. As a public company, it develops and manufactures rapid diagnostic tests and laboratory instruments.

      BIOMÉRIEUX

      bioMérieux is a France-based diagnostics company founded in 1963 with 14,894 employees. As a public company, it specializes in in vitro diagnostics for infectious diseases, industrial microbiology, and clinical diagnostics.

      QIAGEN

      QIAGEN is a Netherlands-based molecular diagnostics company founded in 1984 with 5,500 employees. As a public company, it develops and manufactures sample preparation and molecular testing solutions.

      SYSMEX CORPORATION

      Sysmex Corporation is a Japan-based diagnostics company founded in 1968 with 10,861 employees. As a public company, it manufactures and distributes hematology, hemostasis, and clinical chemistry analyzers.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based life sciences and diagnostics company founded in 1999 with 18,000 employees. As a public company, it provides analytical instruments, software, and services for research and diagnostics.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a China-based medical device company founded in 1991 with 21,288 employees. As a public company, it manufactures and distributes diagnostic imaging, patient monitoring, and laboratory instruments globally.

      Reasons to Buy this Report

      • Japan-Specific Market Sizing : Access precise valuation data for Japan's immunoassay market ($2,214.52M in 2025) with detailed forecasts through 2030, enabling accurate business planning and investment decisions specific to this high-value market.
      • Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, including local and international players, market consolidation trends, and strategic positioning within Asia's most advanced healthcare economy.
      • Demographic-Driven Growth Insights : Leverage detailed analysis of Japan's aging population impact on immunoassay demand, including segment-specific growth drivers and long-term market sustainability factors.
      • Technology Adoption Trends : Gain insights into Japan's rapid adoption of automated immunoassay platforms, laboratory automation preferences, and regulatory requirements shaping technology deployment strategies.
      • Strategic Market Entry Planning : Develop targeted go-to-market strategies with Japan-specific data on hospital networks, clinical laboratory preferences, reimbursement models, and distribution channel opportunities.

      Frequently asked questions

      What is the current size of Japan's immunoassay market?

      Japan's immunoassay market is valued at $2,214.52 million in 2025.

      What is the projected size of Japan's immunoassay market by 2030?

      Japan's immunoassay market is projected to reach $3,135.56 million by 2030.

      What is the CAGR for Japan's immunoassay market?

      Japan's immunoassay market is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2030.

      What factors are driving growth in Japan's immunoassay market?

      Key drivers include Japan's aging population, advanced healthcare infrastructure, rising healthcare expenditure, expansion of point-of-care testing, and emphasis on precision medicine and early disease detection.

      How does Japan's immunoassay market compare to global trends?

      Japan's 7.2% CAGR exceeds the global immunoassay market CAGR of 6.1%, reflecting strong regional demand and healthcare investment.

      RESEARCH METHODOLOGY

      This study analyzes key market dynamics, including drivers, opportunities, restraints, and challenges, as well as major players’ strategies. It also monitors developments among leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study examines the immunoassay market’s competitive landscape by evaluating market participants against criteria within the overarching categories of business and product strategy. To estimate market size, the study employed both top-down and bottom-up approaches. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
      The four steps involved in estimating the market size are as follows:

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

      Primary Research

      In the primary research process, we interviewed various sources from the supply and demand sides to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. We conducted in-depth interviews with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

      The following is a breakdown of the primary respondents:

      Immunoassay Market Size, and Share

      Note 1: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
      Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
      Note 3: Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For global market value, we calculated annual revenue figures using revenue mapping for major product manufacturers and OEMs active in the global immunoassay market. We identified all major product manufacturers at the global and/or country/regional level. We mapped revenue for the respective business segments/subsegments of the major players. Additionally, the global market was split into various segments and subsegments:

      • List of major players in the immunoassay market by region or country
      • Product mapping of various immunoassay manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from immunoassay products (or the nearest reported business unit/product category)
      • Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
      • Summation of revenue of all companies to arrive at the global immunoassay market size

      The data above was consolidated, supplemented with detailed inputs and analysis from MarketsandMarkets, and presented in this report.

      Immunoassay Market: Top-Down and Bottom-Up Approach

      Immunoassay Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall market size using the market size estimation processes, we split the market into several segments and subsegments. To complete the overall market engineering process and arrive at precise statistics for each market segment and subsegment, we used data triangulation and market breakdown procedures, where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides of the immunoassay industry.

      Market Definition

      An immunoassay is a biochemistry-based test that quantifies the presence or concentration of an analyte. An analyte can be a large protein or antibody produced due to an infection. Immunoassays have become popular and well-established procedures in laboratories. They provide quick, accurate, and precise results. This technique is mostly used in clinical diagnostics, drug monitoring, drug discovery, and food testing.

      Key Stakeholders

      • Manufacturers and vendors of immunoassay instruments and consumables
      • Immunoassay product manufacturers
      • Pharmaceutical & biopharmaceutical players
      • Diagnostic associations
      • Research associations involved in infectious and chronic disease research
      • Various research and consulting firms
      • Distributors of immunoassay instruments and consumables
      • Contract manufacturers of immunoassays
      • Healthcare institutions
      • Research institutes
      • Clinical laboratories

      Report Objectives

      • To describe, segment, and forecast the immunoassay market by product, technology, specimen, application, end user, and region in terms of value
      • To forecast the size of the immunoassay market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
      • To provide detailed information about the factors (drivers, restraints, opportunities, and challenges) influencing market growth
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall immunoassay market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To profile the key players in the immunoassay market and comprehensively analyze their core competencies and market shares
      • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the market
      • To benchmark players within the immunoassay market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

      Available customizations:

      Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:

      Geographict Analysis

      • Further breakdown of the Rest of Europe immunoassay market into Switzerland, Denmark, Austria, and others

      • Further breakdown of the Rest of Asia Pacific immunoassay market into Hong Kong, Taiwan, and others

      • Further breakdown of the Rest of Latin America immunoassay market into Argentina, Colombia, Chile, Ecuador, and others

      • Further breakdown of the Southeast Asian immunoassay market into Malaysia, Singapore, Australia, New Zealand, and others

      Competitive Landscape Assessment

      • Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the immunoassay market

      • Competitive leadership mapping for established players in the US

      Get the Full Immunoassay Market Report

      Full forecast, segment splits, and company analysis for all Immunoassay Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status